DRW Securities’s Arcus Biosciences RCUS Stock Holding History

DRW Securities’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,285	Closed	-$108K	–	1571
2025 Q2	$108K	Buy	+13,285	New	+$113K	﹤0.01%	1016

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities's RCUS Position: Q3 2025 in Review

DRW Securities sold out of Arcus Biosciences (RCUS) in Q3 2025, closing a stake of 13,285 shares — an estimated $108K sold.

DRW Securities first reported a position in RCUS in Q2 2025 and held it in 1 quarter. The position peaked at $108K in Q2 2025. 190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

DRW Securities reported no remaining Arcus Biosciences position as of Q3 2025 after selling out during the quarter.
DRW Securities sold 13,285 Arcus Biosciences shares in Q3 2025, an estimated $108K.
DRW Securities first reported a position in Arcus Biosciences in Q2 2025 and held it in 1 quarter.
DRW Securities's Arcus Biosciences position peaked at $108K in Q2 2025.
190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on DRW Securities's 13F filing for Q3 2025, filed 14 Nov 2025.